Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression

Research output: Contribution to journalArticle

Abstract

CCR5 is the primary coreceptor for HIV entry. Early after infection, the HIV viral population diversifies rapidly into a quasispecies. It is not known whether the initial efficiency of the viral quasispecies to utilize CCR5 is associated with HIV disease progression or if it changes in an infected individual over time. The CCR5 and CXCR4 utilization efficiencies (R5-UE and X4-UE) of the HIV quasispecies were examined using a pseudovirus, single-round infection assay for samples obtained from known seroconverters from Rakai district, Uganda (n=88). Initial and longitudinal R5-UE values were examined to assess the association of R5-UE with HIV disease progression using multivariate Cox proportional hazard models. Longitudinal samples were analyzed for 35 seroconverters who had samples available from multiple time points. There was no association between initial or longitudinal changes in R5-UE and the hazard of HIV disease progression (p=0.225 and p=0.942, respectively). In addition, R5-UE increased significantly over time after HIV seroconversion (p

Original languageEnglish (US)
Pages (from-to)289-294
Number of pages6
JournalAIDS Research and Human Retroviruses
Volume28
Issue number3
DOIs
StatePublished - Mar 1 2012

Fingerprint

Disease Progression
HIV
HIV Seropositivity
Uganda
Virus Diseases
Proportional Hazards Models
HIV Infections
Infection
Population

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

@article{f0e6880a6a9b4e15a6e7875b3763344c,
title = "Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression",
abstract = "CCR5 is the primary coreceptor for HIV entry. Early after infection, the HIV viral population diversifies rapidly into a quasispecies. It is not known whether the initial efficiency of the viral quasispecies to utilize CCR5 is associated with HIV disease progression or if it changes in an infected individual over time. The CCR5 and CXCR4 utilization efficiencies (R5-UE and X4-UE) of the HIV quasispecies were examined using a pseudovirus, single-round infection assay for samples obtained from known seroconverters from Rakai district, Uganda (n=88). Initial and longitudinal R5-UE values were examined to assess the association of R5-UE with HIV disease progression using multivariate Cox proportional hazard models. Longitudinal samples were analyzed for 35 seroconverters who had samples available from multiple time points. There was no association between initial or longitudinal changes in R5-UE and the hazard of HIV disease progression (p=0.225 and p=0.942, respectively). In addition, R5-UE increased significantly over time after HIV seroconversion (p",
author = "Redd, {Andrew D.} and Oliver Laeyendecker and Xiangrong Kong and Noah Kiwanuka and Tom Lutalo and Wei Huang and Gray, {Ronald H.} and Wawer, {Maria J.} and David Serwadda and Eshleman, {Susan H.} and Quinn, {Thomas C.}",
year = "2012",
month = "3",
day = "1",
doi = "10.1089/aid.2011.0006",
language = "English (US)",
volume = "28",
pages = "289--294",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression

AU - Redd, Andrew D.

AU - Laeyendecker, Oliver

AU - Kong, Xiangrong

AU - Kiwanuka, Noah

AU - Lutalo, Tom

AU - Huang, Wei

AU - Gray, Ronald H.

AU - Wawer, Maria J.

AU - Serwadda, David

AU - Eshleman, Susan H.

AU - Quinn, Thomas C.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - CCR5 is the primary coreceptor for HIV entry. Early after infection, the HIV viral population diversifies rapidly into a quasispecies. It is not known whether the initial efficiency of the viral quasispecies to utilize CCR5 is associated with HIV disease progression or if it changes in an infected individual over time. The CCR5 and CXCR4 utilization efficiencies (R5-UE and X4-UE) of the HIV quasispecies were examined using a pseudovirus, single-round infection assay for samples obtained from known seroconverters from Rakai district, Uganda (n=88). Initial and longitudinal R5-UE values were examined to assess the association of R5-UE with HIV disease progression using multivariate Cox proportional hazard models. Longitudinal samples were analyzed for 35 seroconverters who had samples available from multiple time points. There was no association between initial or longitudinal changes in R5-UE and the hazard of HIV disease progression (p=0.225 and p=0.942, respectively). In addition, R5-UE increased significantly over time after HIV seroconversion (p

AB - CCR5 is the primary coreceptor for HIV entry. Early after infection, the HIV viral population diversifies rapidly into a quasispecies. It is not known whether the initial efficiency of the viral quasispecies to utilize CCR5 is associated with HIV disease progression or if it changes in an infected individual over time. The CCR5 and CXCR4 utilization efficiencies (R5-UE and X4-UE) of the HIV quasispecies were examined using a pseudovirus, single-round infection assay for samples obtained from known seroconverters from Rakai district, Uganda (n=88). Initial and longitudinal R5-UE values were examined to assess the association of R5-UE with HIV disease progression using multivariate Cox proportional hazard models. Longitudinal samples were analyzed for 35 seroconverters who had samples available from multiple time points. There was no association between initial or longitudinal changes in R5-UE and the hazard of HIV disease progression (p=0.225 and p=0.942, respectively). In addition, R5-UE increased significantly over time after HIV seroconversion (p

UR - http://www.scopus.com/inward/record.url?scp=84863295391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863295391&partnerID=8YFLogxK

U2 - 10.1089/aid.2011.0006

DO - 10.1089/aid.2011.0006

M3 - Article

C2 - 21663455

AN - SCOPUS:84863295391

VL - 28

SP - 289

EP - 294

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 3

ER -